The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas
Menée in vitro et in vivo, cette étude met en évidence un mécanisme par lequel une surexpression du récepteur EphA2 favorise la survie et le potentiel tumorigène des cellules souches de glioblastome
In human glioblastomas (hGBMs), tumor-propagating cells with stem-like characteristics (TPCs) represent a key therapeutic target. We found that the EphA2 receptor tyrosine kinase is overexpressed in hGBM TPCs. Cytofluorimetric sorting into EphA2High and EphA2Low populations demonstrated that EphA2 expression correlates with the size and tumor-propagating ability of the TPC pool in hGBMs. Both ephrinA1-Fc, which caused EphA2 downregulation in TPCs, and siRNA-mediated knockdown of EPHA2 expression suppressed TPCs self-renewal ex vivo and intracranial tumorigenicity, pointing to EphA2 downregulation as a causal event in the loss of TPCs tumorigenicity. Infusion of ephrinA1-Fc into intracranial xenografts elicited strong tumor-suppressing effects, suggestive of therapeutic applications. º Stem-like TPCs in hGBMs highly express the EphA2 receptor º High EphA2 expression supports the undifferentiated state and self-renewal in TPCs º TPC content and tumorigenicity are higher in EphA2High than EphA2Low hGBM cells º EphrinA1-Fc treatment or EPHA2 silencing lessen TPC self-renewal and tumorigenicity